Serial 98311417
Live / Applied — Second extension granted (statement of use) (as of 08 Jan 2026)
What this means for you
Not registered yet, but its 12 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98311417
- Mark type
- Design / logo
- Filed
- 12 Dec 2023
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 001 — Chemicals: chemical, biochemical and biotechnological additives used in industry and science, and in the manufacture of pharmaceuticals and pharmaceutical preparations, for the prevention and treatment of cancer; active chemical ingredients for use in the manufacture of drugs for the prevention and treatment of cancer
- Class 005 — Pharmaceuticals: therapeutic pharmaceuticals for the prevention and treatment of cancer; pharmaceutical products and preparations for the prevention and treatment of cancer; pharmaceutical preparations developed with a computational platform engine using biology and chemistry analytics for the prevention and treatment of cancer
- Class 042 — Scientific and technological services: scientific and medical research and development in the field of pharmaceuticals; scientific and medical research and development in the field of oncology; drug discovery services; pharmaceutical drug development services; drug validation services; providing medical research and scientific research information in the field of pharmaceuticals; providing medical research and scientific research information in the field of oncology; medical and scientific research consulting services in the field of pharmaceuticals and oncology; drug discovery services provided through a computational platform engine used for research and development in the field of oncology
Owner
- Incendia Therapeutics Inc., Boston, MA, US
- Incendia Therapeutics Inc., Boston, MA, US
Prosecution history
- 08 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2026 — SOU EXTENSION 2 GRANTED
- 07 Jan 2026 — SOU EXTENSION 2 FILED
- 07 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jun 2025 — SOU EXTENSION 1 GRANTED
- 25 Jun 2025 — SOU EXTENSION 1 FILED
- 25 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE